Parkinson

National Parkinson Foundation Names New Chief Information Officer

MIAMI, June 5 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced today that Peter N. Schmidt, Ph.D. has been named Chief Information Officer and Director of Programs effective June 1. Dr. Schmidt was most recently Director at Cronus Partners, an investment banking firm...

Tom Lescault, President of SCAN Health Plan Arizona, Appointed to Parkinson Network of Arizona Board of Directors

PHOENIX, June 1 /PRNewswire/ --- Tom Lescault, president of SCAN Health Plan Arizona and president of the Arizona Association of Health Plans, was recently appointed to the Parkinson Network of Arizona board of directors. The mission of the Parkinson Network is to improve the lives of those with P...

The Medtronic Foundation Awards Fourth Grant to the National Parkinson Foundation's National Parkinson Care Network Program

MIAMI, April 7 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) has been awarded its fourth grant from the Medtronic Foundation Patient Link program to address health disparities in Parkinson's disease (PD). Medtronic Foundation funding for the National Parkinson Care Network...

Young Onset Parkinson Conferences: A First-Ever Collaboration

The American Parkinson Disease Association (APDA) and the National Parkinson Foundation (NPF) Announce Plans to Co-Sponsor a Series of Young Onset Parkinson Conferences; First to be held in Dallas, Texas, October 2009 MIAMI , March 13 /PRNewswire-USNewswire/ -- The American Parkins...

The Bachmann-Strauss Dystonia & Parkinson Foundation: New Study Identifies Gene Mutations as Cause of Dystonia in Amish-Mennonite Families

Breakthrough findings contribute to better understanding of little-known disease and may lead to development of new therapies NEW YORK, Feb. 3 /PRNewswire/ -- A new research study has identified mutations in the THAP1 gene as a cause of primary torsion dystonia (DYT6 type) in Amish-Mennonite ...

The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative

MIAMI, Jan. 2 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) awarded five grants for the Falls Prevention Initiative, studying new evidence-based interventions aimed at preventing falls in people with Parkinson's disease. The Falls Prevention Initiative awarded grants to...

Why dopamine freezes parkinson patients and drives drug addicts

CHICAGO -- Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has...

National Parkinson Foundation Awards $3.7 Million in Grants

MIAMI, Aug. 5 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced it will fund $3.7 million in grant programs dedicated to Parkinson's disease research, care and outreach worldwide. Grants were awarded to institutions in the Foundation's network of 44 centers of excell...

American Parkinson Disease Association Awards More Than $3.7 Million to Research

NEW YORK, July 7 /PRNewswire-USNewswire/ -- The American Parkinson Disease Association (APDA) has announced its 2008 research awards, which include a Dr. George C. Cotzias Memorial Fellowship, a Dr. Roger Duvoisin, MD Grant, 31 research grants, 13 post-graduate grants, and six summer medical s...

K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team!

New Business Alliance will help to raise funds and awareness EAGAN, Minn., April 23 /PRNewswire/ -- K2 Logistics, an industry leader focused on single-source supply chain management, knows the significance of teamwork. In that spirit, K2 Logistics, headquartered in Eagan, announced today...

More>>

Parkinson in Medical Technology

Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets

... n eurodegeneration and n euroinflammation in parkinson ' s d isease Antonio Cuadrado, PhD, Univ...cies in the nigrostriatal pathway, as a target for parkinson ' s disease therapy Yoon-Seong Kim, MD, PhD... Polo-like kinases as therapeutic targets for parkinson ' s disease Hilal A. Lashuel, PhD, and Patr...

Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders

...dent and CEO of InSightec. "The results of this study set the ground for extensive brain study addressing the areas of functional diseases like parkinson and Epilepsy, brain tumors and stroke. This technology has the potential to help significant amount of patients while reducing trauma and morbidity. T...

Parkinson's Disease Foundation Awards $300,000 in Bridge Funding for Innovative Research Projects

...ven in a time of economic uncertainty, for promising research to be put on hold." These grants are part of PDF's four-pronged approach to funding parkinson science. PDF's research initiatives include a Center Grants Program, which funds research at three leading universities; the International Research G...

AFFiRiS Begins Development of a Parkinson's Vaccine

...the start of the pre-clinical development of its first Parkinson's vaccine PD01. The vaccine will be investigated for efficacy ("proof of concept") in parkinson models. On successful conclusion of this preclinical evaluation, initial clinical testing could start in 2010/11. The Parkinson's vaccine specifically...

Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels

.... There is human 'proof of concept' clinical data available. A supply of clinical drug product is available for an approved Phase II clinical study in parkinson patients. Persons interested in bidding must sign a Confidentiality Agreement ("CA") obtained from Finn's office - jffinnjr@earthlink.net or 781-2...

New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease

...icating that common mitochondrial DNA lineages modulate the risk for developing a wide variety of diseases including diabetes, cardiovascular disease, parkinson Disease, Alzheimer Disease, various cancers, as well as longevity." The mitochondrial DNA encodes essential genes for mitochondrial energy productio...

U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease

...ich are dosed multiple times a day. Clinical Study FDA approval was based primarily on results from the EASE-PD (Efficacy And Safety Evaluation in parkinson Disease) Adjunct Study, a multi-center, double-blind, placebo-controlled study conducted in patients with idiopathic Parkinson's disease not adequatel...

Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine

...urtz, MD, MPH, of the University of Rochester School of Medicine and Dentistry, heads the Clinical Trial Coordinating Center there and is chair of the parkinson Study Group, a network of top researchers conducting clinical research in PD. About The Michael J. Fox Foundation Founded in 2000, The Michael J...

Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans

...velopment. Dr. Gregory brings more than 15 years of biotechnology/pharmaceutical and academic experience, with special attention to Alzheimer disease, parkinson disease and multiple sclerosis. Dr. Nakas applies more than 22 years of clinical, academic and industry research experience in multiple therapeutic ar...

Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease

...ous delivery of a dopamine agonist for 24 hours, leading to stable plasma levels," said Rajesh Pahwa, M.D., Professor of Neurology and Director of the parkinson Disease and Movement Disorder Center at the University of Kansas Medical Center. "These data showed that Neupro has a positive effect on patients' ear...

More>>

Parkinson in Medical Products

Microguide

Description:...comprising breakthrough for Micro electrode recording and stimulation, used for optimal target localization for the treatment of movement disorders in parkinson disease during DBS Implantation, pallidotomy, thalamotomy and other similar neurosurgical procedures. The system provides all electrophysiological ins...
Company:Alpha Omega Engineering Ltd.

Parkinson in Medical Dictionary

Parkinson

There are other disorders called Parkinson -plus diseases. ... Most idiopathic Parkinson 's disease patients also have Lewy bodies in their ... Research and education for Parkinson's Disease. Includes information on research grants and fellowships as well as patient resources an...

Essential Tremor

...zed Care for Voice Disorders. ... Essential tremor can also involve the larynx, vocal folds and throat, causing ... Management: In 1817, James parkinson differentiated essential tremor from that of other tremors , including parkinsonian tremor Table 1. If an essential tremor occurs in mo...

Parkinson in Biological News

Researchers identify protein pathway involved in Parkinson disease development

Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease. The research ...

Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates

The replenishment of missing neurons in the brain as a treatment for Parkinson disease reached the stage of human trials over 15 years ago, however the field is still in its infancy. Researchers from Kyoto University have now shown that dopamine-producing neurons (DA neurons) generated from monkey ...

Study by NTU professors provides important insight into apoptosis or programmed cell death

...t kills too many cells and inflicts grave tissue damage. This is the case in strokes and neurodegenerative disorders such as Alzheimer, Huntington and parkinson diseases. While it is established that cells undergo apoptosis when they are damaged by mechanical injury, exposed to death stimuli, or under stres...

Work in mice will contribute to the study of hereditary diseases that lead to blindness

...rodegenerative process induced in the retina by intense light exposure. parkinson and Alzheimer The researcher of the UGR insists that "it is important to ...y involved in all the diseases and damages of the nervous system, including parkinson and Alzheimer, and knowing their behaviour in pathologic situations could b...

Neural stem cell differentiation factor discovered

...e human brain. EGFL7 might also be applied as a neuronal differentiation factor in ischemic insults or neurodegenerative diseases such as Alzheimer or parkinson predict both researchers. Future work will unravel in which diseases EGFL7 can unfold its therapeutic potential. ...

Rosenstiel students come out on top

...al Science Foundation (NSF). Ross Cunning and John parkinson were awarded fellowships for their research on cor...continued to work primarily in Baker's coral lab. parkinson also spent a semester abroad at Australia's James ...ity to study corals in the Great Barrier Reef. parkinson was awarded the NSF fellowship for his proposal to...

Parkinson's Disease Foundation awards $300,000 in bridge funding for innovative research projects

... even in a time of economic uncertainty, for promising research to be put on hold." These grants are part of PDF's four-pronged approach to funding parkinson science. PDF's research initiatives include a Center Grants Program, which funds research at three leading universities; the International Research G...

Van Andel Research Institute and TGen undertake alliance to promote science and health

...ility in 2000. Its 18 research laboratories are primarily dedicated to molecular cancer research, but it also focuses on conditions such as diabetes, parkinson disease, osteoporosis, and heart disease. VARI will open a 240,000 square-foot building expansion this fall, which will allow it to broaden its effor...

Parkinson's Disease Foundation announces award of $150,000

...research of the highest caliber that may help us to understand and treat Parkinson's." This grant is part of PDF's four-pronged approach to funding parkinson science. PDF's traditional research initiatives include a Center Grants Program, which funds research at three leading universities; the Internationa...

The Rett Syndrome Research Trust launches operations

...hanism underlying MECP2 disorders is likely to help us understand diseases ranging from autism and schizophrenia to cognitive disorders, epilepsy, and parkinson disease." Monica Coenraads, Executive Director of the Trust, describes the work ahead. "This early stage of drug discovery is unlikely to be a hi...

More>>

Parkinson in Biological Technology

Van Andel Institute Joins the MetaMiner Oncology Partnership Program

...process. Van Andel Research Institute (VARI), the research arm of VAI, is dedicated to probing the genetic, cellular and molecular origins of cancer, parkinson and other diseases and working to translate those findings into effective therapies. This is accomplished through the work of over 200 researchers in ...

Obio Pharmaceutical Announces Product Growth Strategy

... to produce the drug. Apart from the aforementioned drug candidates, the Company continues to push research of its candidates in life-style and parkinson disease arenas. The Company believes that its research focus will achieve the Company vision to research and develop novel drugs, and bring them into ...

Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results

...n and New Zealand Bone and Mineral Society Annual Meeting, August 28-30, 2008, in Melbourne, Australia. -- A poster entitled: "Altropane(R) SPECT in parkinson Disease patients and healthy controls" was presented at the 2nd International Symposium on Neuroimaging in Parkinson's Disease and Related Disorders, ...

Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights

...ement on the design of the two trials is reached with the FDA. -- Data from a study to evaluate the Test/Re-test reliability of ALTROPANE in parkinson disease patients were presented at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders in Ju...

The Parkinson's Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinson's Disease

...utic effect of exercise. A high point of the event will be the presentation, at a celebratory dinner following the first day's program, of the James parkinson Award, PDF's highest honor, which is given only once each decade. This year, the award will go to Dr. Stanley Fahn, in recognition of his lifetime of ...

Gov. Doyle comments on unlocking the power of power of stem cell research

...cience go forward. America should listen to her. My mother suffers from parkinson disease. Our family is no different from the Reagans or millions of others...uffering of so many people. As many as one million Americans suffer from parkinson disease. They should not have to suffer any more delays in the research th...

RFID expert says piecemeal approach won't work

...apabilities of RFID, a lot of companies talk it up as a universal panacea to everybody's problems in business, in logistics and shipping and storage," parkinson said. The RFID lab personal are "very good at clearing up some of the impressions people have gotten, some of the misinformation about how readers and...

Parkinson in Biological Products

Mouse Anti-Human PARK2 Monoclonal Antibody, Unconjugated, Clone 1H4 from Novus Biologicals

Description:... Mouse monoclonal antibody to PARK2 - parkinson disease (autosomal recessive, juvenile) 2, parkin...
Company:Novus Biologicals